the publisher's Medical Devices sector report, “Blood Purification Equipment - Medical Devices Pipeline Product Landscape, 2021' provides comprehensive information about the Blood Purification Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Blood Purification Equipment is to filter blood by removing the irreversibly damaged red blood cells and toxins before transfusion and reduces the occurrence of post-transfusion complications.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
– Extensive coverage of the Blood Purification Equipment under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Blood Purification Equipment and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry
The report enables you to -
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
– Identify and understand important and diverse types of Blood Purification Equipment under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date
Blood Purification Equipment is to filter blood by removing the irreversibly damaged red blood cells and toxins before transfusion and reduces the occurrence of post-transfusion complications.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
– Extensive coverage of the Blood Purification Equipment under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Blood Purification Equipment and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
– Identify and understand important and diverse types of Blood Purification Equipment under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
1 Table of Contents
2 Introduction
3 Products under Development
4 Blood Purification Equipment - Pipeline Products under Development by Companies
7 Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Accel Diagnostics LLC
- Advanced Prenatal Therapeutics, Inc.
- Aethlon Medical Inc
- Asahi Kasei Medical Co Ltd
- Avalon GloboCare Corp
- Boston Children's Hospital
- Cala Medical Ltd
- Cerus Corp
- Chemofilter Inc (Inactive)
- CytoSorbents Corp
- EBO2 Inc
- Eliaz Therapeutics Inc
- Ex Vivo Dynamics Inc
- ExThera Medical Corp
- Filtro Medical Inc
- Good SIRS
- HemoTune AG
- Immunicom Inc
- JIMRO Co Ltd
- Kohane Lab
- Leukocare AG
- McGowan Institute for Regenerative Medicine
- MediSieve Ltd
- Miltenyi Biotec BV & Co KG
- Nipro Corp
- Nonwovens Innovation & Research Institute Ltd
- NuVascular Technologies Inc
- NxStage Medical Inc
- Opsonix Inc
- Pall Medical Products Inc
- Path Ex Inc
- ProSorp BioTech Inc
- Pure Biologics SA
- Recombinant Technologies LLC
- SanSepsis BV
- Santersus AG
- Sigyn Therapeutics Inc
- Toray Medical Co Ltd
- University of Louisville
- Viatar CTC Solutions Inc
- Zata Pharmaceuticals Inc